|Articles|May 23, 2016
Sanofi Loses Three Top Execs in Reshuffle
May 23, 2016.
Advertisement
Three of Sanofi's (Paris, France) top executives are leaving the company as its "2020 strategic roadmap" gets under way.
Pascale Witz, executive vice president of diabetes and cardiovascular, Carsten Hellmann, executive vice president of Merial, Sanofi’s animal health division, and Suresh Kumar, executive vice president of external affairs, have announced their intention to leave the company.
Hellmann has accepted a position as president and CEO of ALK (Horsholm, Denmark).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition
2
FDA Approves Moderna's mRNA-Based Flu Vaccine
3
Amazon Pharmacy Launches GLP-1 Delivery Service
4
Your Questions Answered: The Biggest Pharma Stories of the Week of August 3-7, 2026
5